SAN DIEGO, April 30, 2013 /PRNewswire/ -- Acutus Medical, Inc. (ACM or Company), an emerging developer and manufacturer of medical devices designed to provide real-time 3D cardiac electrical mapping based on dipole density for the treatment of cardiac arrhythmias, announced today that it has performed its First-In-Man clinical study of its cardiac catheter to provide highest-quality real-time 3D mapping of the human heart.
The first four patient procedures were performed by Principal Investigator Professor Mattias Duytschaever, MD, at Sint-Jan Hospital in Brugge, Belgium.
"We are very pleased with the progress of our First-In-Man clinical study and we look forward to the forthcoming studies for our technology in the European markets" said Randy Werneth, CEO/President. "We have the ability in a matter of seconds to generate real-time 3D images of the heart with quality equivalent to a CT or MRI."
About Acutus Medical Since June, 2011, Acutus Medical has pioneered a new and novel approach in the minimally invasive imaging and mapping of cardiac arrhythmias.
Acutus Medical has concentrated its efforts on the developing its technology for the treatment of an aberrant arrhythmia, atrial fibrillation (AF). Acutus Medical believes that its technology may eventually play a significant role in improving the lives of countless individuals who are afflicted by AF.
This press release includes forward-looking statements regarding Acutus Medical Cardiac Imaging and Mapping Technology System. Any statement describing Acutus Medical's goals, expectations, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Acutus goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing products and in the endeavor of building a business around such products. Acutus Medical's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Acutus Medical forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Acutus Medical. As a result, you are cautioned not to rely on these forward-looking statements.
For More Information, please contact: Acutus Medical Mr. Randy Werneth CEO / President [email protected]